Related Blog Posts
Pharmaceutical outsourcing poised for growth, report says
12 hours ago ago from Global Employment News | oDesk Job News
The contract pharmaceutical market will grow 11.1 percent per year between 2009 and 2014, a recently released report from BCC Research says. Contract manufacture of over-the-counter and nutraceutical drugs is the largest segment of pharmaceutical contracting, BCC notes. The compound annual growth rate of the space will be 11.4 percent. The second-largest contract pharmaceutical segment is the manufacture of bulk- and dosage-form drugs; ...
Related contentThe Misery of Pfizer Could Be The Joy Of Texas: Generic Drugs Are On The Rise
15 hours ago ago from The Dallas 10 - Top Ten Lists of the Best Restaurants, Businesses, Services, and Everything Else You Can Imagine in Dallas, TX
Pfizer can't be happy. Its patent on the best-selling drug in the world, Lipitor, expires in 2011, which doesn't give the pharmaceutical giant much time to figure out how to compensate for the billions of dollars in sales that will be lost when it happens, courtesy of generic companies reproducing the medicine's active ingredients. The United States alone buys $5 billion worth of the brand-name drug every year. It's hard to believe that ...
Related contentAPIs And GMP Consulting
2 hours ago ago from Wholesome Diet.net
In the past decade, many pharmaceutical companies have outsourced ingredient production to Asian countries including China and India in the hope of lowering production costs and increasing profits. However GMP Consulting firms have seen a shift back to US based production companies. In this article some of the reasons for the Asian outsourcing failure will be discussed. When pharmaceutical companies decided to move the production if ...
Related contentRelated News
Nothing to see... move along.
Related Videos
Nothing to see... move along.
